China Pharma Holdings (CPHI) Leases (2018 - 2025)
China Pharma Holdings (CPHI) has disclosed Leases for 8 consecutive years, with $197851.0 as the latest value for Q3 2025.
- For the quarter ending Q3 2025, Leases rose 235.73% year-over-year to $197851.0, compared with a TTM value of $197851.0 through Sep 2025, up 235.73%, and an annual FY2024 reading of $38298.0, down 67.16% over the prior year.
- Leases was $197851.0 for Q3 2025 at China Pharma Holdings, up from $19176.0 in the prior quarter.
- Across five years, Leases topped out at $197851.0 in Q3 2025 and bottomed at $19176.0 in Q1 2025.
- Average Leases over 5 years is $92558.3, with a median of $89022.5 recorded in 2022.
- The sharpest move saw Leases plummeted 81.52% in 2023, then surged 390.25% in 2024.
- Year by year, Leases stood at $127958.0 in 2021, then tumbled by 69.49% to $39046.0 in 2022, then skyrocketed by 198.65% to $116610.0 in 2023, then tumbled by 67.16% to $38298.0 in 2024, then skyrocketed by 416.61% to $197851.0 in 2025.
- Business Quant data shows Leases for CPHI at $197851.0 in Q3 2025, $19176.0 in Q1 2025, and $38298.0 in Q4 2024.